Author

Ricardo Risson

Observed names: Ricardo Gustavo Zill Risson, Risson, Ricardo

Institution: Hospital do Rocio

Observed institution: Hospital do Rocio

ORCID: 0009-0005-5583-6408

Observed ORCID: 0009-0005-5583-6408

OpenAlex ID: A5066401481

Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors)

2023 · Lívia Pimenta Bonifácio, Eduardo Ramacciotti, et al. · Revista da Sociedade Brasileira de Medicina Tropical · 10

Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors)

2023 · Bonifácio, Lívia Pimenta, Ramacciotti, Eduardo, et al. · Figshare

Works count: 2

Citation count: 10

H-index: 1

I10-index: 1